Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interferon-2A with ABVD for Hodgkin's Disease
NCT01404936Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Jul 1996
- Primary completion
- Dec 2011
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of interferon alfa-2a in Hodgkin lymphoma (HL), sponsored by University of Texas MD Anderson Cancer Center. Started Jul 1996; status: completed.
02
Drugs
interferon alfa-2a
03
Conditions
Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT01404936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01404936.